Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A New Era in Treatment of Advanced Disease

Prognostic Value of Soluble Programmed Death Ligand-1 (sPD-L1) in Hepatocellular Carcinoma

High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Updates in Cancer Immunotherapy: Review Article

The Expression of Immune Checkpoint Inhibitors PDL-1 and CTLA-4 in Pancreatic Versus Non-Pancreatic Periampullary Adenocarcinoma: An Immunohistochemical Study

Value of Regulatory T Cell in Hepatocellular Carcinoma Patients

The Renaissance of Interest in Breast Cancer Treatment by PD1/PDL1 Checkpoint Inhibitors

Hepatocellular Carcinoma: Diagnosis and Therapeutic Options

PDL1 Immunohistochemical Expression in Thyroid Neoplasms: A Possible Therapeutic Target